Insilico Medicine
http://insilico.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Insilico Medicine
Quantum Outperforms Classical Computer, Finding New KRAS Inhibitors
In a breakthrough for drug discovery, quantum hardware outperformed classical hardware in generating two promising KRAS inhibitors.
Big Tech's Growing Biopharma Prominence
If activity at the recent J.P. Morgan Healthcare Conference is an indication of what is up ahead, 2024 is set to be the year of big tech in biopharma.
Biopharma Must Be Prepared For Era Of Quantum Computing
Quantum computing is both mysterious and prone to hype, but the reality of a quantum era is approaching and the benefits for biopharma could be enormous. Prepare ahead of time to gain a first mover advantage, say the experts.
Exelixis Adds Insilico Deal In Search Of Growth Beyond Cabometyx
After feeling the heat from activist investor Farallon Capital Management earlier this year, CEO Michael Morrissey has defended its spending on in-house R&D and in-licensing as it announced a new oncology deal.
Company Information
- Industry
- Pharmaceuticals
-
Digital Health
- Artificial Intelligence
-
Biotechnology
- Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice